K2M, a spinal device company focused on treatment of complex spinal pathologies, received FDA 510k clearances for its CHESAPEAKE anterior-lumbar stabilization system, according to a company news release.
CHESAPEAKE is an interbody device designed to stabilize the spine through an anterior approach. The system includes the tifix locking technology for screw fixation, in which each screw head forms an autogenic lock to the implant upon insertion.
CHESAPEAKE is manufactured from PEEK polymer and utilizes the anterior insertion ramp and controlled threaded insertion while applying a zero-impact load on the interbody.
Read the K2M release on CHESAPEAKE.
Read other coverage on K2M:
- Welsh Carson Acquires Spinal Device Company K2M
- K2M Introduces Two Minimally Invasive Spine Surgery Products
- K2M Launches Natural Bridge Low Profile Transverse Connectors
CHESAPEAKE is an interbody device designed to stabilize the spine through an anterior approach. The system includes the tifix locking technology for screw fixation, in which each screw head forms an autogenic lock to the implant upon insertion.
CHESAPEAKE is manufactured from PEEK polymer and utilizes the anterior insertion ramp and controlled threaded insertion while applying a zero-impact load on the interbody.
Read the K2M release on CHESAPEAKE.
Read other coverage on K2M:
- Welsh Carson Acquires Spinal Device Company K2M
- K2M Introduces Two Minimally Invasive Spine Surgery Products
- K2M Launches Natural Bridge Low Profile Transverse Connectors